🔗 Share this article

Treasury head Reeves has stated she is preparing "focused measures to address household expense challenges" in next month's financial statement.

In comments to media outlets, she noted that reducing price rises is a joint duty of both the government and the Bank of England.

The UK's inflation rate is forecast to be the highest among the Group of Seven developed nations this year and the following year.

Potential Energy Cost Interventions

Reports indicate the government could intervene to bring down energy bills, for instance by reducing the present 5% rate of value-added tax applied on energy.

A further approach is to cut some of the policy costs presently added to bills.

Budgetary Limitations and Analyst Predictions

The administration will obtain the next report from the official forecaster, the OBR, on Monday, which will show how much scope there is for such measures.

The expectation from most economists is that the Chancellor will have to announce higher taxes or expenditure reductions in order to meet her voluntary debt limits.

Previously on Thursday, analysis suggested there was a £22bn deficit for the chancellor to fill, which is at the more modest range of projections.

"It is a shared job between the Bank of England and the government to further reduce some of the causes of inflation," the Chancellor told reporters in Washington, at the yearly gatherings of the IMF and World Bank.

Revenue Pledges and International Issues

While much of the focus has been on likely tax increases, the Treasury chief said the most recent information from the OBR had not changed her commitment to manifesto promises not to raise rates on earnings tax, sales tax or National Insurance.

She attributed an "uncertain world" with rising geopolitical and trade issues for the fiscal revenue measures, likely to be targeted on those "wealthiest."

International Economic Tensions

Referring to concerns about the United Kingdom's economic relations with China she said: "Our security interests always are paramount."

Last week's statement by Chinese authorities to strengthen export controls on rare earths and other materials that are crucial for advanced tech production led American leader the US President to suggest an further 100% tariff on imports from the Asian country, raising the risk of an all-out commercial conflict between the two economic giants.

The American finance chief labeled the Chinese action "economic coercion" and "a global supply chain control attempt."

Questioned on accepting the US offer to join its battle with China, Reeves said she was "extremely troubled" by Chinese actions and urged the Beijing authorities "not to put up barriers and restrict access."

She said the action was "bad for the global economy and creates additional headwinds."

"In my view there are areas where we need to address Chinese policies, but there are also important opportunities to sell into Chinese markets, including financial services and other areas of the economic system. We've got to achieve that equilibrium correct."

The Treasury chief also confirmed she was collaborating with other major economies "on our own critical minerals approach, so that we are more independent."

NHS Medicine Costs and Funding

The Chancellor also recognized that the price the National Health Service pays for drugs could increase as a consequence of ongoing talks with the US government and its drugs companies, in exchange for reduced taxes and capital.

Some of the world's largest pharmaceutical manufacturers have said in recent statements that they are either halting or scrapping projects in the United Kingdom, with some attributing the modest returns they are receiving.

Last month, the Science Minister said the cost the NHS spends on drugs would need to increase to prevent businesses and pharmaceutical investment leaving the UK.

The Chancellor told the BBC: "It has been observed as a result of the cost structure, that clinical trials, recent pharmaceuticals have not been offered in the United Kingdom in the extent that they are in other European countries."

"The objective is to ensure that people getting care from the National Health Service are can obtain the best critical medicines in the world. And so we are looking at these issues, and... looking to secure increased capital into the UK."